Breast Cancer
In association with clinicians at St Vincents and other hospitals we have developed large tissue banks and patient databases that are being used to identify markers of disease subtype, disease progression and response to particular therapies. A major joint project, with the Cell Cycle and Steroid Hormone Action Groups, aims to identify molecular markers of tamoxifen resistance, since loss of response to tamoxifen is a major reason for treatment failure. We are also conducting collaborative studies with other institutions to define the role of newly-discovered breast cancer genes in the disease process.
Staff
Dr Elena Lopez-Knowles |
|
| Postgraduate Student Dr Sandra O'Toole |
Postgraduate Student Dr Catriona McNeill |
|
Data Clerk |
Data Clerk Edwina Wing-Lun |
| Visiting Scientist Dr Ewan Millar |
Visiting Scientist |
News
Garvan Scientist wins Gustav Nossal Scholarship
30 Mar 2007
Each year the highest ranked applicant for an NHMRC (National Health and Medical Research Council) Medical and Dental Postgraduate Research Scholarship wins the Gustav Nossal Scholarship. This year’s recipient, Dr Sandra Biankin who is using the funds to undertake her PhD at Garvan.
ReEDDucating cancer cells
25 Jan 2005
Dr Michelle Henderson of the Garvan Cancer Research Program has been awarded the Macquarie Bank Cure Cancer Research Fellowship for her work on the role of the EDD gene in cancer development.
